|Bid||40.35 x 800|
|Ask||40.43 x 800|
|Day's Range||40.24 - 41.33|
|52 Week Range||27.85 - 48.50|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Data for patients with the M6-C disc show retention of significant benefits in disability and neck, shoulder/arm pain scores at three and four years.
The OrthoNext™ digital platform enables selection of device size and the optimal positioning for the patient’s body prior to the surgical procedure.
Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended March 31, 2021. Net sales were $105.6 million, earnings per share ("EPS") was $(0.30) and adjusted EPS was $0.17.